Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non???Small-Cell Lung Cancer Guideline, Journal of Clinical Oncology, vol.25, issue.34, pp.5506-5524, 2007. ,
DOI : 10.1200/JCO.2007.14.1226
Options and Recommendations for the management of nonsmall cell lung carcinoma patients, Bull Cancer, vol.90, pp.151-66, 2003. ,
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group, Journal of Clinical Oncology, vol.26, issue.21, pp.3552-3561, 2008. ,
DOI : 10.1200/JCO.2007.13.9030
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB???IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial, The Lancet Oncology, vol.7, issue.9, pp.719-746, 2006. ,
DOI : 10.1016/S1470-2045(06)70804-X
Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non???Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10, Journal of Clinical Oncology, vol.28, issue.1, pp.29-34, 2010. ,
DOI : 10.1200/JCO.2009.24.0333
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer, N Engl J Med, vol.350, pp.351-60, 2004. ,
Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non???Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10, Journal of Clinical Oncology, vol.26, issue.31, pp.5018-5027, 2008. ,
DOI : 10.1200/JCO.2007.12.6094
Essai randomis?? de phase III de chimioth??rapie adjuvante par CDDP/docetaxel versus CDDP/gemcitabine dans les cancers bronchiques non ?? petites cellules r??s??qu??s avec la qualit?? de vie comme objectif principal, Revue des Maladies Respiratoires, vol.23, issue.5, pp.489-96, 2006. ,
DOI : 10.1016/S0761-8425(06)71825-3
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology, JNCI Journal of the National Cancer Institute, vol.85, issue.5, pp.365-76, 1993. ,
DOI : 10.1093/jnci/85.5.365
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials, European Journal of Cancer, vol.30, issue.5, pp.635-677, 1994. ,
DOI : 10.1016/0959-8049(94)90535-5
Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer, Quality of Life Research, vol.16, issue.5, pp.353-64, 1994. ,
DOI : 10.1007/BF00451727
Incorporating quality of life assessment into clinical cancer trials Quality of Life and Pharmacoeconomics in Clinical Trials, pp.1003-1016, 1996. ,
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30, Quality of Life Research, vol.311, issue.6, pp.555-67, 1996. ,
DOI : 10.1007/BF00439229
Interpreting the significance of changes in health-related quality-of-life scores., Journal of Clinical Oncology, vol.16, issue.1, pp.139-183, 1998. ,
DOI : 10.1200/JCO.1998.16.1.139
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer, Annals of Oncology, vol.24, issue.6, pp.1630-1639, 2013. ,
DOI : 10.1093/annonc/mds649
Quality of Life and Symptom Burden among Long-Term Lung Cancer Survivors, Journal of Thoracic Oncology, vol.7, issue.1, pp.64-70, 2012. ,
DOI : 10.1097/JTO.0b013e3182397b3e
Effect of chemotherapy for advanced non-small cell lung cancer on patients??? quality of life, Lung Cancer, vol.53, issue.2, pp.231-240, 2006. ,
DOI : 10.1016/j.lungcan.2006.05.003
Customized Adjuvant Phase II Trial in Patients With Non???Small-Cell Lung Cancer: IFCT-0801 TASTE, Journal of Clinical Oncology, vol.32, issue.12, pp.1256-61, 2014. ,
DOI : 10.1200/JCO.2013.53.1525
Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.30, issue.2, pp.172-180, 2012. ,
DOI : 10.1200/JCO.2010.33.7089
Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.28, issue.19, pp.3138-3183, 2010. ,
DOI : 10.1200/JCO.2009.27.6204
DNA Repair by ERCC1 in Non???Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy, New England Journal of Medicine, vol.355, issue.10, pp.983-91, 2006. ,
DOI : 10.1056/NEJMoa060570
Is class III ??-tubulin a predictive factor in patients receiving tubulin-binding agents?, The Lancet Oncology, vol.9, issue.2, pp.168-75, 2008. ,
DOI : 10.1016/S1470-2045(08)70029-9